Cargando…
Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light
BACKGROUND: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has recently been identified as the causative agent for Coronavirus Disease 2019 (COVID-19). The ability of this agent to be transmitted by blood transfusion has not been documented, although viral RNA has been detected in seru...
Autores principales: | Ragan, Izabela, Hartson, Lindsay, Pidcoke, Heather, Bowen, Richard, Goodrich, Raymond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259667/ https://www.ncbi.nlm.nih.gov/pubmed/32470046 http://dx.doi.org/10.1371/journal.pone.0233947 |
Ejemplares similares
-
Pathogen reduction of monkeypox virus in plasma and whole blood using riboflavin and UV light
por: Ragan, Izabela K., et al.
Publicado: (2023) -
Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies
por: Cardoso, Marcia, et al.
Publicado: (2023) -
Preservation of neutralizing antibody function in COVID‐19 convalescent plasma treated using a riboflavin and ultraviolet light‐based pathogen reduction technology
por: Yonemura, Susan, et al.
Publicado: (2021) -
Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment
por: Keil, Shawn D., et al.
Publicado: (2020) -
Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage
por: Owusu-Ofori, Shirley, et al.
Publicado: (2015)